表紙
市場調查報告書

血液篩檢和血型鑑定:全球市場

Blood Screening and Typing: Global Markets

出版商 BCC Research 商品編碼 816258
出版日期 內容資訊 英文 168 Pages
訂單完成後即時交付
價格
Back to Top
血液篩檢和血型鑑定:全球市場 Blood Screening and Typing: Global Markets
出版日期: 2019年03月27日內容資訊: 英文 168 Pages
簡介

全球血液篩檢和血型鑑定市場預測將從2018年的77億美元,以5.0%的年複合成長率成長到2023年的99億美元。

本報告提供全球血液篩檢和血型鑑定市場相關調查,市場現狀與市場結構,市場規模,技術趨勢等彙整,以及參與企業的簡介等相關資訊。

第1章 簡介

第2章 摘要和亮點

第3章 血液產業概要

  • 血液概要
  • 血液的功能
  • 血液群組的分類
  • 採血與輸血
  • 輸血造成的感染疾病
  • 血液管理問題

第4章 市場定義與趨勢

  • 定義
  • 推動市場的要素
  • 阻礙市場的要素
  • 新興趨勢與技術

第5章 市場區隔分析

  • 各技術
    • 免疫檢測
    • 核酸擴增技術
    • 免疫血液學技術
    • 微生物學技術
    • 利基技術
  • 各終端用戶
    • 參照實驗室
    • 獨立型血庫
    • 醫院
  • 各血液類型
    • 捐贈者血
    • 患者血

第6章 各地區分類

  • 簡介和各地區市場
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 法律規章與償付趨勢

第8章 市場佔有率分析與近幾年的產業趨勢

第9章 企業簡介

圖表

目錄
Product Code: HLC224A

Report Highlights:

The global market for blood screening and typing should grow from $7.7 billion in 2018 to reach $9.9 billion by 2023 at a compound annual growth rate (CAGR) of 5.0% for the period of 2018-2023.

Microbiology as a segment of blood screening and typing market should grow from $2.5 billion in 2018 to reach $3.3 billion by 2023 at a CAGR of 5.1% for the period of 2018-2023.

Nucleic acid amplification as a segment of blood screening and typing market should grow from $1.4 billion in 2018 to reach $1.9 billion by 2023 at a CAGR of 5.6% for the period of 2018-2023.

Report Scope:

This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.

By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.

By end-user the market is segmented into hospitals, standalone blood banks and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.

Report Includes:

  • 31 data tables and 34 additional tables
  • An overview of recent key developments in the global blood screening and typing market and a look ahead at the next five years
  • Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Quantitative data covering the overall market by analyzers, kits, reagents and consumables, immunoassay techniques, technology types, microbiology techniques, blood types and consumer groups
  • Regional dynamics of the blood screening market covering North America, Europe, Asia-Pacific and Rest of the world including countries of South America, Middle East and Africa
  • Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the global blood screening market
  • Company profiles of the leading market players, including Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories, Danaher Corp. and Thermo Fisher Scientific, Inc.

Table of Contents

Chapter 1: Introduction

  • Scope of Report
    • Inclusions
    • Exclusions
  • Information Sources
  • Methodology
    • Market Estimation and Forecast
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Key Findings

Chapter 3: Blood Industry Landscape

  • Overview of Blood
    • Composition of Blood
  • Functions of Blood
  • Classification of Blood Groups
    • ABO Blood Group
    • H Antigen
    • Rhesus System
    • MNS System
    • Lutheran System
    • Kell System
    • Duffy Antigen System
    • Kidd Antigen
  • Blood Collection and Transfusion
    • Types of Blood Establishments and Blood Facilities
    • Methods for Collecting Blood from a Donor
    • Plasma Collection
    • Blood Transfusions
    • Types of Transfusions
    • Complications Associated with Blood Transfusions
  • Transfusion Transmissible Infections
    • National Healthcare Safety Network-Biovigilance Component Hemovigilance Module Surveillance
    • Diseases Contracted from Blood Transfusions and Related Identification Testing
    • Human Immunodeficiency Virus (HIV)
    • Epidemiology of Sexually Transmittable Diseases
    • Blood Screening and Evaluation
    • Efforts to Create a Virus-Free Blood Supply
    • Negative Reactions from Blood Transfusions
    • Blood/Plasma Component Risks
  • Blood Management Issues
    • Availability Issues
    • Bloodless Surgery
    • Safety Issues: Risk Management
    • Blood-Transfusion Fatalities

Chapter 4: Market Definition and Dynamics

  • Definition
    • Blood Screening
    • Blood Grouping and Typing
  • Market Drivers
    • Increasing Incidence of Chronic Diseases and Infections
    • Demand for Blood and Blood Transfusion Services
    • Favorable Safety Regulatory Policies for Blood Products
    • Increase in Automation
  • Market Restraints
    • Government Policies
    • Price Pressure on Manufacturers
    • Shortage of Skilled Laboratory Technicians
  • Emerging Trends and Opportunities
    • Multiplexing for Blood Screening
    • Development of Novel Technologies: DNA Sequencing and Microarray Technologies

Chapter 5: Market Segment Analysis

  • Segment Analysis, by Technology
    • Immunoassay
    • Market Size and Forecast
  • Nucleic Acid Amplification Technology
    • Polymerase Chain Reaction Amplification
    • Other Nucleic Acid Amplification Technologies
    • Market Size and Forecast
  • Immunohematology (Blood Typing) Techniques
    • Manual Typing Methods
    • Automated Blood Typing
    • Market Size and Forecast
  • Microbial Techniques
    • Blood Stream Infections
    • Blood Cell Culture and Antimicrobial Susceptibility Testing
    • BioMerieux's VITEK 2 System
    • Becton, Dickinson and Company's BD Phoenix Identification and Susceptibility Testing System
    • Market Size and Forecast
  • Niche Emerging Technologies
    • DNA Sequencing
    • Microarray
    • Market Size and Forecast
  • Segment Analysis, by End User
    • Reference Laboratories
    • Standalone Blood Banks
    • Hospitals
  • Segment Analysis, by Blood Type
    • Donor Blood
    • Patient Blood

Chapter 6: Market Breakdown by Region

  • Introduction and Regional Markets
  • North America
    • U.S.
    • Canada
    • Mexico
    • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Rest of the World (RoW)
    • South America
    • Middle East and Africa

Chapter 7: Regulatory and Reimbursement Landscape

  • Regulations in United States
    • Statutory Authority of the FDA
    • Major Regulations and Policy Matters Concerning the U.S. Blood Supply
    • Implementation of Regulations
    • Guidance for Industry Recognition and Use of a Standard for the Uniform Labeling of Blood and Blood Components
    • Other Organizations Involved in Blood Regulation
    • Voluntary Regulation, by Professional and Trade Associations
  • Reimbursement Landscape in United States
    • Preventive Care Services
  • Regulations in Europe
    • The International Society for Blood Transfusion: ISBT 128
  • Regulations in the Asia-Pacific
  • Regulations in Central and South America
  • Regulations in the Middle East and Africa

Chapter 8: Market Share Analysis and Recent Industry Developments

  • Market Share Analysis
  • Market Share Analysis in the Nucleic Acid Test Segment
  • Market Share Analysis in the Immunoassay Tests Segment
  • Market Share Analysis in the Immunohematology Segment
  • Market Share Analysis in the Microbiology Segment
  • Recent Industry Developments

Chapter 9: Company Profiles

  • ABBOTT LABORATORIES
  • AGENA BIOSCIENCE
  • AXO SCIENCE
  • BAG HEALTH CARE GMBH
  • BECTON, DICKINSON AND CO.
  • BIO-RAD LABORATORIES
  • BIOMERIEUX SA
  • DANAHER CORP.
  • DAY MEDICAL SA
  • DIAGAST
  • F. HOFFMANN-LA ROCHE LTD.
  • GRIFOLS S.A.
  • IMMUCOR
  • NOVACYT GROUP
  • ORTHO CLINICAL DIAGNOSTICS
  • QUOTIENT
  • SIEMENS HEALTHCARE GMBH
  • THERMO FISHER SCIENTIFIC, INC.

List of Tables

  • Summary Table: Global Market for Blood Screening and Typing, by Technology, Through 2023
    • Table 1: Composition of Blood Plasma
    • Table 2: Types of Cellular Elements Present in Blood
    • Table 3: Diseases That can be Treated with Plasmapheresis
    • Table 4: Red Blood Cells Compatibility
    • Table 5: Compatibility of ABO and RH Systems
    • Table 6: Selected Uses of Fresh Frozen Plasma
    • Table 7: Usage and Therapeutic Effect of Cryoprecipitate
    • Table 8: U.S. Major Diseases Contracted from Blood Transfusions
    • Table 9: Chlamydia Incidence in Selected Countries, 2012-2017
    • Table 10: Global HSV-1 Prevalence, Aged 0-49 years, 2012
    • Table 11: Gonorrhea Epidemiology in Selected Countries, 2012-2017
    • Table 12: HIV Incidence, by Country, 2005-2016
    • Table 13: Syphilis Incidence, by Country, 2013-2016
    • Table 14: Factors to Reduce Risks of Transfusion-Associated Diseases
    • Table 15: Transfusion-Related Fatalities, by Complication, 2008-2013
    • Table 16: Fatalities Not Related to Transfusion or Transfusion Not Ruled Out, FY2008-FY2013
    • Table 17: Post-Donation "Not Ruled Out" Fatality Reports, by Donated Product, FY2008-FY2013
    • Table 18: Global Market for Blood Screening and Typing, by Technology, Through 2023
    • Table 19: Global Market for Immunoassay Tests, by Region, Through 2023
    • Table 20: Selected PCR Screening Tests, by Type
    • Table 21: Global Market for Nucleic Acid Amplification Technology, by Region, Through 2023
    • Table 22: Global Market for Immunohematology Devices, by Region, Through 2023
    • Table 23: Global Market for Microbial Techniques, by Region, Through 2023
    • Table 24: Global Market for Niche Technologies, by Region, Through 2023
    • Table 25: Global Market for Blood Screening and Typing, by End User, Through 2023
    • Table 26: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, Through 2023
    • Table 27: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, Through 2023
    • Table 28: Global Market for Blood Screening and Typing in Hospitals, by Region, Through 2023
    • Table 29: Global Market for Blood Screening and Typing, by Type, Through 2023
    • Table 30: Global Market for Donor Blood Testing Equipment, by Region, Through 2023
    • Table 31: Global Market for Patient Blood Testing Equipment, by Region, Through 2023
    • Table 32: Global Market for Blood Screening and Typing, by Region, Through 2023
    • Table 33: North American Market for Blood Screening and Typing, by Country, Through 2023
    • Table 34: European Market for Blood Screening and Typing, by Country, Through 2023
    • Table 35: Asia-Pacific Market for Blood Screening and Typing, by Country, Through 2023
    • Table 36: Donation and Distribution (JRCS 2015)
    • Table 37: RoW Market for Blood Screening and Typing, by Country, Through 2023
    • Table 38: Federal Organizations Responsible for U.S. Blood Safety
    • Table 39: FDA Authority in Regulating Blood Banking and Blood Products
    • Table 40: Major Areas of Concern for Inspecting Blood Facilities
    • Table 41: Classification of In Vitro Diagnostic Devices Under the European IVDR
    • Table 42: Leading Companies, by Technology Segment
    • Table 43: Recent Industry Developments, February 2016-December 2018
    • Table 44: Abbott Laboratories: Company Net Revenue, 2015-2017
    • Table 45: Abbott Laboratories: Products
    • Table 46: Becton, Dickinson and Co.: Company Net Revenue, 2015-2017
    • Table 47: Becton, Dickinson and Co.: Products and Services
    • Table 48: Bio-Rad Laboratories: Company Net Revenue, 2015-2017
    • Table 49: Bio-Rad Laboratories: Products and Services
    • Table 50: Biomerieux SA: Company Net Revenue, 2015-2017
    • Table 51: BioMerieux SA: Products and Services
    • Table 52: Danaher Corp.: Company Net Revenue, 2015-2017
    • Table 53: Danaher Corp.: Products and Services
    • Table 54: F. Hofmann-La Roche Ltd.: Company Net Revenue, 2015-2017
    • Table 55: F. Hofmann-La Roche Ltd.: Products and Services
    • Table 56: Grifols S.A: Company Net Revenue, 2015-2017
    • Table 57: Grifols S.A: Products and Services
    • Table 58: Immucor: Company Net Revenue, 2014-2016
    • Table 59: Immucor: Products and Services
    • Table 60: Ortho Clinical: Diagnostics Products and Services
    • Table 61: Siemens Healthineers GmbH: Company Net Revenue, 2015-2017
    • Table 62: Siemens Healthineers GmbH: Products and Services
    • Table 63: Thermo Fisher Scientific, Inc.: Company Net Revenue, 2015-2017
    • Table 64: Thermo Fischer Scientific, Inc.: Products and Services

List of Figures

  • Summary Figure A: Global Market for Blood Screening and Typing, by Technology, 2017-2023
  • Summary Figure B: Global Market Share for Blood Screening and Typing, by Technology, 2017
    • Figure 1: HIV Infected Population, by Region, 2016
    • Figure 2: Projected Increase in Workforce Needs in the U.S., 2016-2026
    • Figure 3: Global Market for Blood Screening and Typing, by Technology, 2017-2023
    • Figure 4: Global Market Share for Blood Screening and Typing, by Technology, 2017
    • Figure 5: Global Market for Immunoassay Tests, by Region, 2017-2023
    • Figure 6: Global Market Share for Immunoassay Tests, by Region, 2017
    • Figure 7: Global Market for Nucleic Acid Amplification Technology, by Region, 2017-2023
    • Figure 8: Global Market Share for Nucleic Acid Amplification Technology, by Region, 2017
    • Figure 9: Global Market for Immunohematology Devices, by Region, 2017-2023
    • Figure 10: Global Market Share for Immunohematology Devices, by Region, 2017
    • Figure 11: Global Market for Microbial Techniques, by Region, 2017-2023
    • Figure 12: Global Market Share for Microbial Techniques, by Region, 2017
    • Figure 13: Global Market for Niche Technologies, by Region, Through 2023
    • Figure 14: Global Market Share for Niche Technologies, by Region, 2017
    • Figure 15: Global Market for Blood Screening and Typing, by End User, 2017-2023
    • Figure 16: Global Market Share for Blood Screening and Typing, by End User, 2017
    • Figure 17: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, 2017-2023
    • Figure 18: Global Market Share for Blood Screening and Typing in Reference Laboratories, by Region, 2017
    • Figure 19: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017-2023
    • Figure 20: Global Market Share for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017
    • Figure 21: Global Market for Blood Screening and Typing in Hospitals, by Region, 2017-2023
    • Figure 22: Global Market Share for Blood Screening and Typing in Hospitals, by Region, 2017
    • Figure 23: Global Market for Blood Screening and Typing, by Type, 2017-2023
    • Figure 24: Global Market Share for Blood Screening and Typing, by Type, 2017
    • Figure 25: Global Market for Donor Blood Testing Equipment, by Region, 2017-2023
    • Figure 26: Global Market Share for Donor Blood Testing Equipment, by Region, 2017
    • Figure 27: Global Market for Patient Blood Testing Equipment, by Region, 2017-2023
    • Figure 28: Global Market Share for Patient Blood Testing Equipment, by Region, 2017
    • Figure 29: Global Market for Blood Screening and Typing, by Region, 2017-2023
    • Figure 30: Global Market Share for Blood Screening and Typing, by Region, 2017
    • Figure 31: North American Market for Blood Screening and Typing, by Country, 2017-2023
    • Figure 32: North American Market Share for Blood Screening and Typing, by Country, 2017
    • Figure 33: European Market for Blood Screening and Typing, by Country, 2017-2023
    • Figure 34: European Market Share for Blood Screening and Typing, by Country, 2017
    • Figure 35: Asia-Pacific Market for Blood Screening and Typing, by Country, 2017-2023
    • Figure 36: Asia-Pacific Market Share for Blood Screening and Typing, by Country, 2017
    • Figure 37: RoW Market for Blood Screening and Typing, by Country, 2017-2023
    • Figure 38: RoW Market Share for Blood Screening and Typing, by Country, 2017
    • Figure 39: Global Market Share Analysis of Blood Screening and Typing, by Company, 2017
    • Figure 40: Nucleic Acid Test, Market Share Analysis, by Company, 2017
    • Figure 41: Immunoassay Tests, Market Share Analysis, by Company, 2017
    • Figure 42: Immunohematology, Market Share Analysis, by Company, 2017
    • Figure 43: Microbiology, Market Share Analysis, by Company, 2017
    • Figure 44: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
    • Figure 45: Abbott Laboratories: Revenue, by Country, 2015-2017
    • Figure 46: Abbott Laboratories: Revenue Share, by Diagnostics Segment, 2017
    • Figure 47: Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2017
    • Figure 48: Becton, Dickinson and Co.: Revenue Share, by Region/Country, 2017
    • Figure 49: Bio-Rad Laboratories: Revenue, by Business Segment, 2015-2017
    • Figure 50: Bio-Rad Laboratories: Revenue, by Region/Country, 2015-2017
    • Figure 51: Bio-Rad Laboratories Revenue Share, by Region/Country, 2017
    • Figure 52: BioMerieux SA: Revenue, by Business Segment, 2015-2017
    • Figure 53: BioMerieux SA: Revenue, by Region, 2015-2017
    • Figure 54: Danaher Corp.: Revenue, by Business Segment, 2015-2017
    • Figure 55: Danaher Corp.: Revenue, by Region, 2015-2017
    • Figure 56: Danaher Corp.: Revenue Share, by Diagnostics, 2017
    • Figure 57: Danaher Corp.: Revenue Share, by Region, 2017
    • Figure 58: F. Hofmann-La Roche Ltd.: Revenue, by Business Segment, 2015-2017
    • Figure 59: F. Hofmann-La Roche Ltd.: Revenue, by Diagnostics Segment, 2015-2017
    • Figure 60: F. Hofmann-La Roche Ltd.: Revenue, by Region, 2015-2017
    • Figure 61: Grifols S.A: Revenue, by Business Segment, 2015-2017
    • Figure 62: Grifols S.A: Revenue Share, by Business Segment, 2015-2017
    • Figure 63: Immucor: Revenue, by Business Segment, 2014-2016
    • Figure 64: Immucor: Revenue, by Region/Country, 2014-2016
    • Figure 65: Siemens Healthineers GmbH: Revenue, by Business Segment, 2015-2017
    • Figure 66: Siemens Healthineers GmbH: Revenue Share, by Business Segment, 2017
    • Figure 67: Siemens Healthineers GmbH: Revenue Share, by Diagnostics Segment, 2017
    • Figure 68: Siemens Healthineers GmbH: Revenue Share, by Region, 2017
    • Figure 69: Thermo Fischer Scientific, Inc.: Revenue Share, by Business Unit, 2017
    • Figure 70: Thermo Fischer Scientific, Inc.: Revenue Share, by Country, 2017
Back to Top